Replies to post #135528 on Biotech Values

[ghmm]

Seems like it would be an awkward therapy for AD patients... Sub-q may be a slight improvement though :-).

I recall you posting a while back about how expensive this would be on the health care system (if successful of course). Any idea on capacity, could enough immunoglobulin be produced? I guess plasma "donations" would become more lucrative.